Assyro AI

Orange Book product · Generic (ANDA)

ENZALUTAMIDE

ENZALUTAMIDE

Generic (ANDA)ANDA 209667DISCN ZYDUS PHARMS

At a glance

Sep 26, 2024

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Sep 26, 2024

    1 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ENZALUTAMIDE

Strength

40MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

ANDA 209667

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ENZALUTAMIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.